Bloodstream infections are potentially life-threatening conditions that require rapid identification of the causative agent in order to facilitate a specific antimicrobial therapy. Rapid bacterial identification and susceptibility testing not only improves patient therapy and outcome but can also reduce costs and may prevent the development of bacterial resistance, for instance by allowing a shorter duration of antimicrobial therapy or an early switch from empirically administered broadspectrum antibiotics to narrow-spectrum substances (8, 15, 18) .
Several methods for direct detection and susceptibility testing of bacteria in positive blood cultures have been described, including PCR methods, as well as DNA and RNA probes and restriction fragment length polymorphism profile analysis (4) . The target sequences of the primers and probes were the eubacterial 16S rRNA gene and family-, genus-, or speciesspecific genes for identification of the bacteria, as well as specific resistance genes, such as the staphylococcal mecA gene, for the determination of antimicrobial susceptibility (2, 5, (9) (10) (11) (12) . The application of fluorescence-based real-time PCR even allowed specific detection of pathogenic bacteria in blood cultures within a few hours (17) . However, there is no commercial kit for molecular diagnostics of blood cultures yet available and standardization of the assays is lacking. In addition to molecular methods, the Vitek 2 system has recently been evaluated for the identification and susceptibility testing of pathogenic bacteria by direct inoculation from positive BACTEC blood culture bottles and showed promising results (13) . However, thus far these evaluations have exclusively used gram-negative bacilli, and problems with the identification of gram-positive cocci have been described (1) .
Recently, a commercially available test kit, the Hyplex BloodScreen multiplex PCR-enzyme-linked immunosorbent assay (ELISA) system (BAG, Lich, Germany), has been developed that facilitates direct identification of pathogenic bacteria from positive blood culture bottles within few hours. Independently of the result of the initial Gram stain, a PCR assay for either gram-positive or gram-negative bacteria is applied. For subsequent hybridization in an ELISA-based format, the assay is made up of a panel of test modules (microtiter plate cavities coated with a specific probe) for the identification of Escherichia coli, Pseudomonas aeruginosa, Enterobacter aerogenes, Klebsiella spp., Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, and Enterococcus faecalis/Enterococcus faecium. In addition, the staphylococcal mecA gene can be detected with a specific test.
In the present study, we first evaluated the Hyplex BloodScreen multiplex PCR-ELISA system for the direct identification of pathogenic bacteria and the detection of the staphylo-coccal mecA gene on 482 positive aerobic and anaerobic BACTEC 9240 blood culture bottles. The results of the Hyplex BloodScreen test were compared to the results of culture and biochemical identification as "gold standard."
MATERIALS AND METHODS
Sample collection and bacterial strains. Samples consisted of 482 positive BACTEC 9240 blood culture bottles, including 376 aerobic and 106 anaerobic bottles from patients of all departments of the hospital of Ulm University. Samples were collected between July 2001 and August 2002 after automatic detection of the bottles in the BACTEC 9240 (Becton Dickinson) blood culture system and processed in parallel to routine diagnostics. On each day of collection, all blood cultures positive with gram-positive cocci, gram-negative cocci, or gram-negative rods in the initial Gram stain, including mixtures of different bacteria, were used, and no preselection of samples was done. In cases where both the aerobic and the anaerobic bottle were detected to be positive, only the aerobic bottle was included in the study.
Cultural identification of bacteria. Identification and differentiation of bacteria grown in BACTEC 9240 bottles was performed according to the results of the Gram stain. Identification of all bacteria apart from most staphylococci was done by Api (Api 20 Strep, Api Rapid ID 32 Strep, Api NH, Api 20E, and Api 20NE [all from BioMerieux]). For staphylococci, diagnosis was based on typical morphology (color, hemolysis, etc.), a positive catalase reaction, positive clumping factor (Slidex; BioMerieux), positive aurease detection (BioMerieux), and mannitol-salt-agar detection. If differentiation was ambiguous, an Api Staph analysis was performed.
Susceptibility testing. Methicillin resistance in S. aureus was detected by determination of PBP2a by a latex agglutination test (MRSA Screen; Innogenetics, Ghent, Belgium) and phenotypically by growth on Mueller-Hinton agar supplemented with 6 g of oxacillin and 4% NaCl (Heipha)/ml. In coagulase-negative staphylococci (CNS), oxacillin resistance was determined phenotypically by agar diffusion test according to the NCCLS guideline M100-S11, with a 1-g oxacillin disk on Muller-Hinton agar supplemented with 2% NaCl. An inhibition zone of Յ17 mm indicated resistance to oxacillin. In addition, oxacillin MIC was determined by microbouillon (broth) dilution on the Merlin Micronaut System (Merlin) by using a range of 0.25 to 32 g of oxacillin of 2% NaCl in the assay. In all strains, the results of both methods were consistent.
DNA preparation. Total DNA from positive blood culture bottles was prepared by an alkali wash lysis method, according to the protocol of Millar et al. (14) . Briefly, 0.5 ml of inoculated blood culture medium was mixed with 1.0 ml of alkali wash solution (0.5 M NaOH, 0.05 M sodium citrate) and then further mixed on a rotator for 10 min at room temperature. The suspension was centrifuged at 13,000 ϫ g for 5 min, the pellet was washed twice in 0.5 ml of 0.5 M Tris-HCl (pH 8.0) and centrifuged as described above, and the resulting pellet was resuspended in 0.1 ml of Tris-EDTA (10 mM Tris-HCl [pH 8.0], 1 mM EDTA). The suspension was transferred in a screw-cap reaction tube, incubated at 95°C for 10 min, and subjected to two cycles of 2 min of freezing in liquid nitrogen and 2 min of boiling in a boiling water bath (freezing at Ϫ20°C for 5 to 10 min each was also effective). After a centrifugation step at 13,000 ϫ g for 15 min, the supernatant was stored at Ϫ20°C until use in the Hyplex BloodScreen test.
Hyplex BloodScreen multiplex PCR-ELISA system. The Hyplex BloodScreen multiplex PCR-ELISA system (version 1; BAG) involves an initial amplification of the bacterial DNA by multiplex PCR and a subsequent hybridization of the PCR product to specific oligonucleotide probes in an ELISA-based format with color-coded wells. The test takes ca. 4.5 to 6 h, including DNA isolation, PCR amplification, and detection by hybridization. Positive samples are identified by measurement of the optical densities (ODs) in the ELISA plate wells. An OD of Ͻ0.2 has been defined as negative, an OD between 0.2 and 0.4 has been defined as borderline, and an OD of Ͼ0.4 has been defined as positive by the manufacturer. All samples with borderline results (Ͻ2% of all samples) were repeated three times (extending the turnaround time of the assay for ϳ2.5 h), and the means of the measurements were considered. The system includes a grampositive PCR kit for the amplification of the DNA of gram-positive bacteria and test modules (microtiter plate cavities coated with a specific probe) for the detection of S. aureus, S. epidermidis, E. faecalis/E. faecium, S. pyogenes, S. pneumoniae, and the staphylococcal mecA gene, as well as a gram-negative PCR kit for the amplification of the DNA of gram-negative bacteria and test modules for the detection of E. coli, P. aeruginosa, E. aerogenes, and Klebsiella spp. Target genes of the assay are species-specific housekeeping genes. The test was performed as indicated by the manufacturer except for the use of 0.5-ml reaction tubes (instead of 0.2-ml tubes) for the multiplex PCR on a thermal cycler (Thermal Cycler Touch Down; Hybaid, Ashford, United Kingdom) and the following modification of the PCR protocol: a denaturation time of 1 min, an annealing time of 1 min, and an elongation time of 90 s.
Nucleotide sequence analysis of PCR products. The nucleotide sequences of amplicons were determined in eight samples in which the biochemical identification of certain bacterial isolates was found to be ambiguous or divergent with respect to the PCR result. Briefly, the primers 16sfor (AGAGTTTGATCCTG GCTCAG) and 16srev (GTTTACCTTGTTACGACTT) were used as sequencing primers; these primers span a region from positions 8 to 1509 of the eubacterial 16S rRNA gene (7) . Amplification products were purified by using the HighPure PCR product purification kit (Roche Diagnostics), and cycle sequencing reactions of the eubacterial 16S ribosomal DNA (rDNA) sequence were performed as described in the dye terminator cycle sequencing ready reaction kit (ABI Prism Biosystems). The fluorescence-labeled reaction products were analyzed with a ABI Prism 310 genetic analyzer. Obtained sequences were compared to the GenBank/EMBL databank for identification of isolates. Identification was defined as a sequence homology of Ն98.5% with the respective strain in the database.
LightCycler PCR assays. For confirmation of the identification of S. epidermidis and the mecA gene in selected samples, LightCycler PCR assays with hybridization probes were performed. For the identification of S. epidermidis, primer DG74 and RW01, amplifying a 386-bp fragment of the 16S rRNA gene, and the probes EpiFL and EpiLC were used according to the protocol published by Wellinghausen et al. (17) . For identification of the mecA gene, primers Mec-F2 and Mec-R2 and probes Mec-HP-1 and Mec-HP-2 were used strictly according to the protocol published by Reischl et al. (16) .
RESULTS

Identification of samples with gram-negative microscopy.
In 140 blood cultures, exclusively gram-negative bacteria were visible in the initial Gram stain and grown in pure culture. In all samples, the PCR assay for gram-negative bacteria and the hybridization modules for E. coli, P. aeruginosa, Klebsiella spp., and E. aerogenes were applied. Compared to culture and subsequent biochemical identification, the diagnostic sensitivity of the assays resulted in 100% (Table 1) . For the E. aerogenes assay, the sensitivity was not determined since no isolate of this species was included in the panel of samples tested. Regarding diagnostic specificity, the Klebsiella spp. and the E. aerogenes assay also had a specificity of 100%. The P. aeruginosa assay showed a specificity of 98.5% since cross-reactions with Citrobacter koseri and Enterobacter cloacae were observed. However, these false-positive results had much lower OD values than the true positive isolates and only reached the cutoff OD value of 0.4, which discriminates borderline and positive samples, as stated by the manufacturer ( Table 1) . The E. coli assay showed a specificity of only 92.5% since cross-reactions with Bacteroides fragilis, E. cloacae, and Morganella morganii were observed. Although OD values of the false-positive samples that contained B. fragilis and M. morganii clearly differed from the OD values from the true positive samples (median OD of Ͻ0.6 versus 2.5, P Ͻ 0.001 by Mann-Whitney U test; see also Table  1 ), the false-positive E. cloacae isolate had an OD value similar to that of E. coli (Table 1) . Identification of this E. cloacae isolate was further confirmed by 16S rDNA sequencing (99.6% homology to the respective strain in the database).
Identification of samples with gram-positive microscopy. In 309 blood cultures, exclusively gram-positive cocci were visible in the initial Gram stain and grew in pure culture. In all samples, the PCR assay for gram-positive bacteria and the hybridization modules for S. aureus, S. epidermidis, E. faecium/ E. faecalis, S. pyogenes, and S. pneumoniae, as well as the mecA gene, were applied. A sensitivity of 100% was observed for the S. aureus and S. pneumoniae modules. The E. faecalis/E. fae-cium module repeatedly revealed borderline positive OD values (median OD of 0.23) in one sample of E. faecium, most probably due to low amount of DNA in the sample. The diagnostic sensitivity of the S. pyogenes module could not be calculated since no isolate of this species was included in the panel of samples tested.
All assays had a diagnostic specificity exceeding 97.5%. The S. epidermidis module showed false-positive results with three samples of CNS, four samples of E. faecalis and one sample of Streptococcus mitis (Table 2 ). In these eight samples, an S. epidermidis-specific LightCycler PCR was also performed that resulted in a positive signal in six of the eight samples, suggesting the simultaneous presence of S. epidermidis DNA, possibly due to contamination of the sample during preparation of the blood culture. Both samples of CNS, which were false positive in the Hyplex BloodScreen test but negative in the S. epidermidis LightCycler PCR, were identified as S. hominis by 16S rDNA sequencing and, thus, must be regarded as "true" false positives. The E. faecalis/E. faecium module was positive in one isolate of Enterococcus durans that was identified by Api ID 32 Strep (code 32115701351). 16S rDNA sequencing of this isolate revealed the highest similarity (99.8%) to the 16S rDNA of E. faecium, which might explain the positive test result. The S. pneumoniae module reacted positively in one isolate of E. faecalis and in one isolate of S. mitis. The falsepositive result of the S. mitis can be explained since this isolate harbors the PCR target gene (unpublished data). The S. aureus and the S. pyogenes module had specificities of even 100% ( Table 2) .
Identification of the mecA gene of staphylococci in pure culture. The Hyplex BloodScreen test for the detection of the mecA gene was applied in all samples showing gram-positive bacteria in the Gram stain. Apart from staphylococci, no other isolates reacted positive in the mecA test. In S. aureus, the mecA gene was detected in all methicillin-resistant S. aureus strains (n ϭ 3) and in none of the phenotypically confirmed methicillin-susceptible S. aureus isolates (n ϭ 35).
Concerning S. epidermidis, 95.8% of the phenotypically resistant isolates (136 of 142) and 94.4% of the phenotypically susceptible isolates (34 of 36) were correctly identified in the mecA assay (Table 3 ). In these isolates, which reacted as false negative (n ϭ 6) or false positive (n ϭ 2) in the Hyplex BloodScreen assay compared to the phenotypic result, an additional mecA gene LightCycler PCR was performed. This PCR confirmed the presence of the mecA gene in all false-negative isolates. Both "false-positive" isolates were also confirmed to carry the mecA gene and therefore have to be considered as true positives.
Concerning CNS except S. epidermidis, the Hyplex BloodScreen mecA test yielded false-negative results in 12 of 20 phenotypically resistant isolates, and the additionally performed mecA gene LightCycler PCR confirmed the presence of the mecA gene in all isolates. Interestingly, 9 of 12 isolates were identified as S. haemolyticus. All phenotypically susceptible CNS were correctly identified by the mecA test (Table 3) .
Identification of samples showing a mixture of gram-negative and gram-positive bacteria.
A mixed culture of different species of bacteria was grown in 33 samples. In 22 samples a (Table 4) . Since the S. epidermidis PCR was also positive in both samples growing S. epidermidis, the Hyplex BloodScreen test result might be regarded as true positive. The additional detection of Klebsiella spp. in two samples appears plausible since both samples were obtained from the same patient treated in the MICU for sepsis and large-bowel necrosis. The two samples positive for S. aureus were from two patients with abdominal sepsis and urosepsis, respectively. Of the 15 isolates of S. epidermidis grown in a mixed culture, 13 were phenotypically resistant to oxacillin. In 5 of these 13 isolates mecA gene detection was false negative, including all four samples that were false negative for S. epidermidis. Falsepositive results were not seen with the mecA gene detection test.
DISCUSSION
In the present study, the Hyplex BloodScreen PCR-ELISA system was evaluated for the first time for direct identification of pathogenic bacteria in a large panel of positive BACTEC 9240 blood culture bottles. This test system allows identification of the bacteria within ca. 4.5 to 6 h, including DNA isolation, PCR amplification, and detection by reverse hybridization. Therefore, in contrast to conventional culture and biochemical identification techniques, which usually take 1 to 2 days, the Hyplex BloodScreen PCR-ELISA system generates results much quicker.
Concerning pure cultures of bacteria, the Hyplex Blood- The Hyplex BloodScreen PCR-ELISA system not only allows identification of the most important pathogenic bacteria causing bloodstream infections in humans but also includes a test module for the detection of the mecA gene in staphylococci that codes for methicillin susceptibility. In our study, the detection of the mecA gene in S. aureus proved 100% sensitive and specific. Phenotypic detection of methicillin resistance in CNS is difficult due to the heterogeneous expression of the Although it is stated by the manufacturer that the test should only be used on aerobic blood culture bottles, we decided, since all of the species covered by the test represent aerobically growing bacteria, to include both aerobic and anaerobic blood culture bottles since, in our experience, aerobically growing bacteria, especially staphylococci and Enterobacteriaceae, are sometimes found in anaerobic blood culture bottles. For instance, in our study 29 of 133 aerobic or facultative anaerobic gram-negative rods, including 16 of 58 isolates of E. coli, were detected in the anaerobic blood culture bottle.
In conclusion, the Hyplex BloodScreen PCR-ELISA system is well suited for the direct and specific identification of the most common pathogenic bacteria in positive blood cultures. It allows earlier identification of pathogenic bacteria compared to routine cultures and may contribute to a timely and costeffective pathogen-adapted antimicrobial therapy even before availability of phenotypic antimicrobial susceptibility testing results. In addition, it also allows early sensitive and specific detection of the mecA gene in S. aureus.
